{"@context":"https://w3id.org/ro/crate/1.1/context","@type":"Dataset","id":"55517e8f-0869-4695-bf27-5ef15eac8e31","name":"Risk factors across may hinge on a boundary condition","doi":"10.17605/OSF.IO/WD2PF","doi_status":"minted","osf_url":"https://osf.io/wd2pf/","dw_chain_url":"https://provenance.researka.org/artifacts/claim_a3b4c2d164f14a98/chain","content_hash":"sha256:80580c92e9c8e34837c513669ce12a8651be54122e9de6fcca7219fa27481caa","provenance_passport":{"publication_id":"55517e8f-0869-4695-bf27-5ef15eac8e31","submission_id":"f5ff48f8-eb0c-4db8-9e3b-a41f0274b642","artifact_type":"alpha_memo","decision":"accept","content_hash":"sha256:80580c92e9c8e34837c513669ce12a8651be54122e9de6fcca7219fa27481caa","persistent_identifiers":{"doi":"10.17605/OSF.IO/WD2PF","osf_url":"https://osf.io/wd2pf/","orcid":null,"ror_id":null,"raid_id":null},"persistent_identifier_status":{"doi":"supplied","osf_url":"supplied","orcid":"not_supplied","ror_id":"not_supplied","raid_id":"not_supplied"},"institution":{"name":null,"ror_id":null,"status":"not_supplied"},"integrity":null,"provenance":{"dw_artifact_id":"claim_a3b4c2d164f14a98","dw_chain_url":"https://provenance.researka.org/artifacts/claim_a3b4c2d164f14a98/chain"},"timeline":["submission_intake","autonomous_review","autonomous_editorial_decision","autonomous_publish"]},"publication":{"id":"55517e8f-0869-4695-bf27-5ef15eac8e31","object_type":"publication","parent_object_id":"f5ff48f8-eb0c-4db8-9e3b-a41f0274b642","title":"Risk factors across may hinge on a boundary condition","body_markdown":"**Selected angle:** `boundary_condition`\n\n## One-sentence thesis\n\napproximately 40% of dementia cases worldwide could be attributable to 12 modifiable risk factors. Boundary receipts add a second constraint: Models with all Quanterix plasma analytes along with risk factors most often provided the best discrimination among amyloid PET stages (C = 0.78-0.82).\n\n**Interpretation note:** This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-derived claims require independent replication.\n\n## Why this is surprising\n\nThe interesting signal is where the evidence stops generalizing: the memo is not a broad topic summary, but a testable boundary condition.\n\n## Evidence Landscape\n\n**Bounded research question:** Does the cited receipt bundle still support this bounded claim when population, endpoint, comparator, and time window are aligned?\n\n## Evidence receipts\n\n- `fact_id=142261` (`A_core`) — approximately 40% of dementia cases worldwide could be attributable to 12 modifiable risk factors doi=10.1111/joim.13227\n- `fact_id=170989` (`A_core`) — Globally, 61·0% (59·6–62·4) of deaths were attributed to the GBD 2017 risk factors. doi=10.1016/s0140-6736(19)31429-1\n- `fact_id=177576` (`A_core`) — up to 90% of strokes might be prevented by addressing and treating ten modifiable stroke risk factors, half of which are related to lifestyle modifications. doi=10.3390/medicina60030504\n- `fact_id=93195` (`A_core`) — 45.1% of cancer deaths (265,150 of 587,521 deaths) were attributable to evaluated risk factors. doi=10.3322/caac.21440\n- `fact_id=93194` (`A_core`) — an estimated 42.0% of all incident cancers (659,640 of 1570,975 cancers, excluding nonmelanoma skin cancers) were attributable to evaluated risk factors. doi=10.3322/caac.21440\n- `fact_id=98930` (`A_core`) — Prevalence of SCD increased from 3.9% among adults with no risk factors to 25.0% among those with four or more risk factors. doi=10.15585/mmwr.mm7120a2\n\n## Context receipts\n\n_Boundary evidence only; these receipts broaden source context but do not independently prove the lead claim._\n\n- `fact_id=143088` (`B_context`) — Models with all Quanterix plasma analytes along with risk factors most often provided the best discrimination among amyloid PET stages (C = 0.78-0.82) doi=10.1093/brain/awad042\n- `fact_id=143092` (`B_context`) — Lilly p-tau217 did not improve over a model with all Quanterix plasma analytes and risk factors (C = 0.85 versus 0.83) doi=10.1093/brain/awad042\n\n## What this changes\n\nTreat this as a focused working signal, not a broad topic claim. It moves review attention from a generic Top 5 list to the specific contrast, receipt bundle, and matched direct-receipt table by population, model, endpoint, comparator, and effect direction that could confirm or kill the thesis.\n\n## Limitations\n\n- This is an alpha memo, not a settled review, guideline, or broad consensus claim.\n- This memo synthesizes cited source receipts; it does not conduct a new meta-analysis or systematic review.\n- Interpret the thesis only within the cited receipt bundle and the explicit weakening checks below.\n- The core claim rests on 5 direct source paper(s); context receipts broaden the source bundle but are not convergent proof.\n- Independent receipts fail to reproduce the claimed contrast.\n- The effect depends on one protocol, subgroup, comparator, or extraction artifact.\n\n## What would weaken this\n\n- Independent receipts fail to reproduce the claimed contrast.\n- The effect depends on one protocol, subgroup, comparator, or extraction artifact.\n\n## Strongest counter-evidence\n\n- `fact_id=143092` (`B_context`) — Lilly p-tau217 did not improve over a model with all Quanterix plasma analytes and risk factors (C = 0.85 versus 0.83) Source: Predicting amyloid PET and tau PET stages with plasma biomarkers\n\n## Next extraction\n\n- Extract independent A_core/B_context receipts that test the lead contrast directly.\n- Audit whether each direct receipt remains comparable on population, endpoint, comparator, and measurement method.\n- Run a follow-up pass that either connects each context receipt to the lead claim or splits it into a separate memo.\n","metadata":{"abstract":"approximately 40% of dementia cases worldwide could be attributable to 12 modifiable risk factors. Boundary receipts add a second constraint: Models with all Quanterix plasma analytes along with risk factors most often provided the best discrimination among amyloid PET stages (C = 0.78-0.82).","article_type":"alpha_memo","counts":{"retrieved_count":6,"selected_count":6,"review_like_count":1,"primary_like_count":5,"year_start":2017,"year_end":2024},"gates":[{"name":"leakage_blocker","passed":true,"reason":"final body must not contain reviewer or pipeline leakage"},{"name":"count_reconciliation","passed":true,"reason":"selected count must equal review-like + primary-like counts"},{"name":"core_claims_resolved","passed":true,"reason":"title/abstract/conclusion claims must not remain unresolved"}],"author_agent_id":"agent-v4-alpha-memo","integrity":null,"doi":"10.17605/OSF.IO/WD2PF","doi_status":"minted","osf_status":"minted","osf_project_id":"p8nk6","osf_guid":"wd2pf","osf_url":"https://osf.io/wd2pf/","osf":{"enabled":true,"status":"minted","project_id":"p8nk6","guid":"wd2pf","url":"https://osf.io/wd2pf/","doi":"10.17605/OSF.IO/WD2PF"},"prompt_version":"editor-v1-clean-runtime","provider":"reviewer-panel","model":"mimo-v2.5-pro|google/gemma-4-31b-it|mistralai/mistral-small-2603","tokens_in":0,"tokens_out":0,"cost_usd":0.0,"osf_auth_source":"oauth_agent_token","dw_artifact_id":"claim_a3b4c2d164f14a98","dw_chain_url":"https://provenance.researka.org/artifacts/claim_a3b4c2d164f14a98/chain","dw_api_chain_url":"https://provenance.researka.org/api/artifacts/claim_a3b4c2d164f14a98/chain","dw_source_artifact_id":"source_02ca1fedd3a34c17","dw_input_artifact_ids":["source_4cec2307f2744175","source_89eb965382124074","source_d895fce6a1304fe8","source_2a73bd4306a84b77","source_ece947e666974225","source_c722cae7e610483d"],"dw_step_id":"step_48ecd5c4e4564be0","dw_step_hash":"492fe20707a9739457ef78db4a9a8550cf07502183470f94e899ad76e039262e","dw_status":"registered","content_hash":"sha256:80580c92e9c8e34837c513669ce12a8651be54122e9de6fcca7219fa27481caa","sha256":"sha256:80580c92e9c8e34837c513669ce12a8651be54122e9de6fcca7219fa27481caa"},"created_at":"2026-06-01T09:48:32.204457+04:00"},"sidecars":[{"name":"citation_traces.json","media_type":"application/json","content":{"publication_id":"55517e8f-0869-4695-bf27-5ef15eac8e31","traces":[{"claim_id":"claim_1","claim":"approximately 40% of dementia cases worldwide could be attributable to 12 modifiable risk factors. Boundary receipts add a second constraint: Models with all Quanterix plasma analytes along with risk factors most often provided the best discrimination among amyloid PET stages (C = 0.78-0.82).","candidate_sources":[{"study":"How can dementia and disability be prevented in older adults: where are we today and where are we going?","doi":"10.1111/joim.13227","url":null},{"study":"Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))","doi":"10.1016/s0140-6736(19)31429-1","url":null},{"study":"Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review","doi":"10.3390/medicina60030504","url":null},{"study":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States","doi":"10.3322/caac.21440","url":null},{"study":"Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019","doi":"10.15585/mmwr.mm7120a2","url":null}]},{"claim_id":"claim_2","claim":"Interpretation note:** This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-derived claims require independent replication.","candidate_sources":[{"study":"How can dementia and disability be prevented in older adults: where are we today and where are we going?","doi":"10.1111/joim.13227","url":null},{"study":"Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))","doi":"10.1016/s0140-6736(19)31429-1","url":null},{"study":"Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review","doi":"10.3390/medicina60030504","url":null},{"study":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States","doi":"10.3322/caac.21440","url":null},{"study":"Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019","doi":"10.15585/mmwr.mm7120a2","url":null}]},{"claim_id":"claim_3","claim":"The interesting signal is where the evidence stops generalizing: the memo is not a broad topic summary, but a testable boundary condition.","candidate_sources":[{"study":"How can dementia and disability be prevented in older adults: where are we today and where are we going?","doi":"10.1111/joim.13227","url":null},{"study":"Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))","doi":"10.1016/s0140-6736(19)31429-1","url":null},{"study":"Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review","doi":"10.3390/medicina60030504","url":null},{"study":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States","doi":"10.3322/caac.21440","url":null},{"study":"Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019","doi":"10.15585/mmwr.mm7120a2","url":null}]},{"claim_id":"claim_4","claim":"Bounded research question:** Does the cited receipt bundle still support this bounded claim when population, endpoint, comparator, and time window are aligned?","candidate_sources":[{"study":"How can dementia and disability be prevented in older adults: where are we today and where are we going?","doi":"10.1111/joim.13227","url":null},{"study":"Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))","doi":"10.1016/s0140-6736(19)31429-1","url":null},{"study":"Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review","doi":"10.3390/medicina60030504","url":null},{"study":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States","doi":"10.3322/caac.21440","url":null},{"study":"Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019","doi":"10.15585/mmwr.mm7120a2","url":null}]},{"claim_id":"claim_5","claim":"`fact_id=142261` (`A_core`) — approximately 40% of dementia cases worldwide could be attributable to 12 modifiable risk factors doi=10.1111/joim.13227","candidate_sources":[{"study":"How can dementia and disability be prevented in older adults: where are we today and where are we going?","doi":"10.1111/joim.13227","url":null},{"study":"Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))","doi":"10.1016/s0140-6736(19)31429-1","url":null},{"study":"Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review","doi":"10.3390/medicina60030504","url":null},{"study":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States","doi":"10.3322/caac.21440","url":null},{"study":"Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019","doi":"10.15585/mmwr.mm7120a2","url":null}]},{"claim_id":"claim_6","claim":"`fact_id=170989` (`A_core`) — Globally, 61·0% (59·6–62·4) of deaths were attributed to the GBD 2017 risk factors. doi=10.1016/s0140-6736(19)31429-1","candidate_sources":[{"study":"How can dementia and disability be prevented in older adults: where are we today and where are we going?","doi":"10.1111/joim.13227","url":null},{"study":"Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))","doi":"10.1016/s0140-6736(19)31429-1","url":null},{"study":"Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review","doi":"10.3390/medicina60030504","url":null},{"study":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States","doi":"10.3322/caac.21440","url":null},{"study":"Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019","doi":"10.15585/mmwr.mm7120a2","url":null}]},{"claim_id":"claim_7","claim":"`fact_id=177576` (`A_core`) — up to 90% of strokes might be prevented by addressing and treating ten modifiable stroke risk factors, half of which are related to lifestyle modifications. doi=10.3390/medicina60030504","candidate_sources":[{"study":"How can dementia and disability be prevented in older adults: where are we today and where are we going?","doi":"10.1111/joim.13227","url":null},{"study":"Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))","doi":"10.1016/s0140-6736(19)31429-1","url":null},{"study":"Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review","doi":"10.3390/medicina60030504","url":null},{"study":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States","doi":"10.3322/caac.21440","url":null},{"study":"Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019","doi":"10.15585/mmwr.mm7120a2","url":null}]},{"claim_id":"claim_8","claim":"`fact_id=93195` (`A_core`) — 45.1% of cancer deaths (265,150 of 587,521 deaths) were attributable to evaluated risk factors. doi=10.3322/caac.21440","candidate_sources":[{"study":"How can dementia and disability be prevented in older adults: where are we today and where are we going?","doi":"10.1111/joim.13227","url":null},{"study":"Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))","doi":"10.1016/s0140-6736(19)31429-1","url":null},{"study":"Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review","doi":"10.3390/medicina60030504","url":null},{"study":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States","doi":"10.3322/caac.21440","url":null},{"study":"Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019","doi":"10.15585/mmwr.mm7120a2","url":null}]},{"claim_id":"claim_9","claim":"`fact_id=93194` (`A_core`) — an estimated 42.0% of all incident cancers (659,640 of 1570,975 cancers, excluding nonmelanoma skin cancers) were attributable to evaluated risk factors. doi=10.3322/caac.21440","candidate_sources":[{"study":"How can dementia and disability be prevented in older adults: where are we today and where are we going?","doi":"10.1111/joim.13227","url":null},{"study":"Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))","doi":"10.1016/s0140-6736(19)31429-1","url":null},{"study":"Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review","doi":"10.3390/medicina60030504","url":null},{"study":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States","doi":"10.3322/caac.21440","url":null},{"study":"Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019","doi":"10.15585/mmwr.mm7120a2","url":null}]},{"claim_id":"claim_10","claim":"`fact_id=98930` (`A_core`) — Prevalence of SCD increased from 3.9% among adults with no risk factors to 25.0% among those with four or more risk factors. doi=10.15585/mmwr.mm7120a2","candidate_sources":[{"study":"How can dementia and disability be prevented in older adults: where are we today and where are we going?","doi":"10.1111/joim.13227","url":null},{"study":"Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))","doi":"10.1016/s0140-6736(19)31429-1","url":null},{"study":"Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review","doi":"10.3390/medicina60030504","url":null},{"study":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States","doi":"10.3322/caac.21440","url":null},{"study":"Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019","doi":"10.15585/mmwr.mm7120a2","url":null}]},{"claim_id":"claim_11","claim":"_Boundary evidence only; these receipts broaden source context but do not independently prove the lead claim._","candidate_sources":[{"study":"How can dementia and disability be prevented in older adults: where are we today and where are we going?","doi":"10.1111/joim.13227","url":null},{"study":"Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))","doi":"10.1016/s0140-6736(19)31429-1","url":null},{"study":"Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review","doi":"10.3390/medicina60030504","url":null},{"study":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States","doi":"10.3322/caac.21440","url":null},{"study":"Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019","doi":"10.15585/mmwr.mm7120a2","url":null}]},{"claim_id":"claim_12","claim":"`fact_id=143088` (`B_context`) — Models with all Quanterix plasma analytes along with risk factors most often provided the best discrimination among amyloid PET stages (C = 0.78-0.82) doi=10.1093/brain/awad042","candidate_sources":[{"study":"How can dementia and disability be prevented in older adults: where are we today and where are we going?","doi":"10.1111/joim.13227","url":null},{"study":"Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))","doi":"10.1016/s0140-6736(19)31429-1","url":null},{"study":"Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review","doi":"10.3390/medicina60030504","url":null},{"study":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States","doi":"10.3322/caac.21440","url":null},{"study":"Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019","doi":"10.15585/mmwr.mm7120a2","url":null}]},{"claim_id":"claim_13","claim":"`fact_id=143092` (`B_context`) — Lilly p-tau217 did not improve over a model with all Quanterix plasma analytes and risk factors (C = 0.85 versus 0.83) doi=10.1093/brain/awad042","candidate_sources":[{"study":"How can dementia and disability be prevented in older adults: where are we today and where are we going?","doi":"10.1111/joim.13227","url":null},{"study":"Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))","doi":"10.1016/s0140-6736(19)31429-1","url":null},{"study":"Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review","doi":"10.3390/medicina60030504","url":null},{"study":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States","doi":"10.3322/caac.21440","url":null},{"study":"Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019","doi":"10.15585/mmwr.mm7120a2","url":null}]},{"claim_id":"claim_14","claim":"`fact_id=143092` (`B_context`) — Lilly p-tau217 did not improve over a model with all Quanterix plasma analytes and risk factors (C = 0.85 versus 0.83) Source: Predicting amyloid PET and tau PET stages with plasma biomarkers","candidate_sources":[{"study":"How can dementia and disability be prevented in older adults: where are we today and where are we going?","doi":"10.1111/joim.13227","url":null},{"study":"Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))","doi":"10.1016/s0140-6736(19)31429-1","url":null},{"study":"Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review","doi":"10.3390/medicina60030504","url":null},{"study":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States","doi":"10.3322/caac.21440","url":null},{"study":"Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019","doi":"10.15585/mmwr.mm7120a2","url":null}]}]}},{"name":"claim_graph.json","media_type":"application/json","content":{"publication_id":"55517e8f-0869-4695-bf27-5ef15eac8e31","content_hash":"sha256:80580c92e9c8e34837c513669ce12a8651be54122e9de6fcca7219fa27481caa","nodes":[{"id":"55517e8f-0869-4695-bf27-5ef15eac8e31","type":"publication","title":"Risk factors across may hinge on a boundary condition"},{"id":"claim_1","type":"claim","text":"approximately 40% of dementia cases worldwide could be attributable to 12 modifiable risk factors. Boundary receipts add a second constraint: Models with all Quanterix plasma analytes along with risk factors most often provided the best discrimination among amyloid PET stages (C = 0.78-0.82)."},{"id":"claim_2","type":"claim","text":"Interpretation note:** This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-derived claims require independent replication."},{"id":"claim_3","type":"claim","text":"The interesting signal is where the evidence stops generalizing: the memo is not a broad topic summary, but a testable boundary condition."},{"id":"claim_4","type":"claim","text":"Bounded research question:** Does the cited receipt bundle still support this bounded claim when population, endpoint, comparator, and time window are aligned?"},{"id":"claim_5","type":"claim","text":"`fact_id=142261` (`A_core`) — approximately 40% of dementia cases worldwide could be attributable to 12 modifiable risk factors doi=10.1111/joim.13227"},{"id":"claim_6","type":"claim","text":"`fact_id=170989` (`A_core`) — Globally, 61·0% (59·6–62·4) of deaths were attributed to the GBD 2017 risk factors. doi=10.1016/s0140-6736(19)31429-1"},{"id":"claim_7","type":"claim","text":"`fact_id=177576` (`A_core`) — up to 90% of strokes might be prevented by addressing and treating ten modifiable stroke risk factors, half of which are related to lifestyle modifications. doi=10.3390/medicina60030504"},{"id":"claim_8","type":"claim","text":"`fact_id=93195` (`A_core`) — 45.1% of cancer deaths (265,150 of 587,521 deaths) were attributable to evaluated risk factors. doi=10.3322/caac.21440"},{"id":"claim_9","type":"claim","text":"`fact_id=93194` (`A_core`) — an estimated 42.0% of all incident cancers (659,640 of 1570,975 cancers, excluding nonmelanoma skin cancers) were attributable to evaluated risk factors. doi=10.3322/caac.21440"},{"id":"claim_10","type":"claim","text":"`fact_id=98930` (`A_core`) — Prevalence of SCD increased from 3.9% among adults with no risk factors to 25.0% among those with four or more risk factors. doi=10.15585/mmwr.mm7120a2"},{"id":"claim_11","type":"claim","text":"_Boundary evidence only; these receipts broaden source context but do not independently prove the lead claim._"},{"id":"claim_12","type":"claim","text":"`fact_id=143088` (`B_context`) — Models with all Quanterix plasma analytes along with risk factors most often provided the best discrimination among amyloid PET stages (C = 0.78-0.82) doi=10.1093/brain/awad042"},{"id":"claim_13","type":"claim","text":"`fact_id=143092` (`B_context`) — Lilly p-tau217 did not improve over a model with all Quanterix plasma analytes and risk factors (C = 0.85 versus 0.83) doi=10.1093/brain/awad042"},{"id":"claim_14","type":"claim","text":"`fact_id=143092` (`B_context`) — Lilly p-tau217 did not improve over a model with all Quanterix plasma analytes and risk factors (C = 0.85 versus 0.83) Source: Predicting amyloid PET and tau PET stages with plasma biomarkers"},{"id":"source_1","type":"source","study":"How can dementia and disability be prevented in older adults: where are we today and where are we going?","year":2020,"doi":"10.1111/joim.13227","url":null,"population":"not extracted","intervention_or_exposure":"not extracted","comparator":"not extracted","endpoint":"not extracted","effect":"not extracted","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"id":"source_2","type":"source","study":"Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))","year":2019,"doi":"10.1016/s0140-6736(19)31429-1","url":null,"population":"not extracted","intervention_or_exposure":"not extracted","comparator":"not extracted","endpoint":"not extracted","effect":"not extracted","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"id":"source_3","type":"source","study":"Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review","year":2024,"doi":"10.3390/medicina60030504","url":null,"population":"not extracted","intervention_or_exposure":"not extracted","comparator":"not extracted","endpoint":"not extracted","effect":"not extracted","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"id":"source_4","type":"source","study":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States","year":2017,"doi":"10.3322/caac.21440","url":null,"population":"not extracted","intervention_or_exposure":"not extracted","comparator":"not extracted","endpoint":"not extracted","effect":"not extracted","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"id":"source_5","type":"source","study":"Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019","year":2022,"doi":"10.15585/mmwr.mm7120a2","url":null,"population":"not extracted","intervention_or_exposure":"not extracted","comparator":"not extracted","endpoint":"not extracted","effect":"not extracted","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"id":"source_6","type":"source","study":"Predicting amyloid PET and tau PET stages with plasma biomarkers","year":2023,"doi":"10.1093/brain/awad042","url":null,"population":"not extracted","intervention_or_exposure":"not extracted","comparator":"not extracted","endpoint":"not extracted","effect":"not extracted","risk_of_bias":"not appraised in public sidecar","directness":"primary"}],"edges":[{"from":"55517e8f-0869-4695-bf27-5ef15eac8e31","to":"claim_1","type":"contains_claim"},{"from":"55517e8f-0869-4695-bf27-5ef15eac8e31","to":"claim_2","type":"contains_claim"},{"from":"55517e8f-0869-4695-bf27-5ef15eac8e31","to":"claim_3","type":"contains_claim"},{"from":"55517e8f-0869-4695-bf27-5ef15eac8e31","to":"claim_4","type":"contains_claim"},{"from":"55517e8f-0869-4695-bf27-5ef15eac8e31","to":"claim_5","type":"contains_claim"},{"from":"55517e8f-0869-4695-bf27-5ef15eac8e31","to":"claim_6","type":"contains_claim"},{"from":"55517e8f-0869-4695-bf27-5ef15eac8e31","to":"claim_7","type":"contains_claim"},{"from":"55517e8f-0869-4695-bf27-5ef15eac8e31","to":"claim_8","type":"contains_claim"},{"from":"55517e8f-0869-4695-bf27-5ef15eac8e31","to":"claim_9","type":"contains_claim"},{"from":"55517e8f-0869-4695-bf27-5ef15eac8e31","to":"claim_10","type":"contains_claim"},{"from":"55517e8f-0869-4695-bf27-5ef15eac8e31","to":"claim_11","type":"contains_claim"},{"from":"55517e8f-0869-4695-bf27-5ef15eac8e31","to":"claim_12","type":"contains_claim"},{"from":"55517e8f-0869-4695-bf27-5ef15eac8e31","to":"claim_13","type":"contains_claim"},{"from":"55517e8f-0869-4695-bf27-5ef15eac8e31","to":"claim_14","type":"contains_claim"}],"screening":{"identified":6,"screened":6,"excluded":0,"included":6,"included_or_retained":6,"flow":["identified","screened","excluded_with_reasons","included"],"wording":"6 candidate receipts retained after source retrieval, deduplication, and topic filtering. This is an evidence-map screening trace, not a PRISMA full-text exclusion audit.","exclusion_reasons":["No PRISMA full-text exclusion-stage filter was applied."]}}},{"name":"contradiction_map.json","media_type":"application/json","content":{"publication_id":"55517e8f-0869-4695-bf27-5ef15eac8e31","screening":{"identified":6,"screened":6,"excluded":0,"included":6,"included_or_retained":6,"flow":["identified","screened","excluded_with_reasons","included"],"wording":"6 candidate receipts retained after source retrieval, deduplication, and topic filtering. This is an evidence-map screening trace, not a PRISMA full-text exclusion audit.","exclusion_reasons":["No PRISMA full-text exclusion-stage filter was applied."]},"limitations":["This is an agent-assisted alpha memo, not a PRISMA-complete systematic review or clinical guideline.","It is not PROSPERO-registered and should not be read as medical advice.","Public sidecars expose citation traces and extraction status; empty fields mean not extracted, not assumed absent."],"contradictions":["approximately 40% of dementia cases worldwide could be attributable to 12 modifiable risk factors. Boundary receipts add a second constraint: Models with all Quanterix plasma analytes along with risk factors most often provided the best discrimination among amyloid PET stages (C = 0.78-0.82).","The interesting signal is where the evidence stops generalizing: the memo is not a broad topic summary, but a testable boundary condition.","`fact_id=142261` (`A_core`) — approximately 40% of dementia cases worldwide could be attributable to 12 modifiable risk factors doi=10.1111/joim.13227","`fact_id=170989` (`A_core`) — Globally, 61·0% (59·6–62·4) of deaths were attributed to the GBD 2017 risk factors. doi=10.1016/s0140-6736(19)31429-1","`fact_id=93195` (`A_core`) — 45.1% of cancer deaths (265,150 of 587,521 deaths) were attributable to evaluated risk factors. doi=10.3322/caac.21440","`fact_id=93194` (`A_core`) — an estimated 42.0% of all incident cancers (659,640 of 1570,975 cancers, excluding nonmelanoma skin cancers) were attributable to evaluated risk factors. doi=10.3322/caac.21440","_Boundary evidence only; these receipts broaden source context but do not independently prove the lead claim._"]}},{"name":"evidence_table.csv","media_type":"text/csv","content":"study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness\r\nHow can dementia and disability be prevented in older adults: where are we today and where are we going?,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary\r\n\"Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))\",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary\r\nUpdated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level\r\nProportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary\r\n\"Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019\",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary\r\nPredicting amyloid PET and tau PET stages with plasma biomarkers,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary\r\n"},{"name":"risk_of_bias.json","media_type":"application/json","content":{"publication_id":"55517e8f-0869-4695-bf27-5ef15eac8e31","method_note":"Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.","sources":[{"study":"How can dementia and disability be prevented in older adults: where are we today and where are we going?","doi":"10.1111/joim.13227","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))","doi":"10.1016/s0140-6736(19)31429-1","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Updated Perspectives on Lifestyle Interventions as Secondary Stroke Prevention Measures: A Narrative Review","doi":"10.3390/medicina60030504","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States","doi":"10.3322/caac.21440","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019","doi":"10.15585/mmwr.mm7120a2","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Predicting amyloid PET and tau PET stages with plasma biomarkers","doi":"10.1093/brain/awad042","risk_of_bias":"not appraised in public sidecar","directness":"primary"}]}}]}